Surprise manufacturing facility inspections have restarted in India, but US Food and Drug Administration Commissioner Robert Califf said that the same program in China remains delayed.
“The plan is to have hundreds of unannounced or short-notice inspections that we’ll be able to report back to you about,” Califf told members of the House Appropriations Subcommittee on Agriculture, Rural Development, the FDA and Related
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?